Selection of CD271+ cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow

Cytotherapy

Volumn 11, Issue 2, 2009, Pages 153-162

  Poloni, A ^a   Maurizi, G ^a   Rosini, V ^a   Mondini, E ^a   Mancini, S ^a   Discepoli, G ^b   Biasio, S ^b   Battaglini, G ^a   Felicetti, S ^a   Berardinelli, E ^a   Serrani, F ^a   Leoni, P ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

Bone marrow mesenchymal stromal cells; CD271 positive cells; Expansion; human AB serum

Indexed keywords

NESTIN; OCTAMER TRANSCRIPTION FACTOR 4; REX PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW CELL; CD271 SELECTION; CELL ADHESION; CELL DIFFERENTIATION; CELL EXPANSION; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CELL SELECTION; CELL STRUCTURE; CELL VIABILITY; CHILD; CONTROLLED STUDY; CULTURE MEDIUM; FEASIBILITY STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; IMMUNOPHENOTYPING; IN VITRO STUDY; KARYOTYPE; MESENCHYMAL STROMA CELL; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; SCHOOL CHILD; STROMA CELL;

ANIMALS; ANTIGENS, DIFFERENTIATION; BONE MARROW CELLS; CATTLE; CELL ADHESION; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; CULTURE MEDIA; FLOW CYTOMETRY; HISTOCOMPATIBILITY; HUMANS; MESENCHYMAL STEM CELLS; NERVE TISSUE PROTEINS; RECEPTORS, NERVE GROWTH FACTOR; SERUM; STROMAL CELLS;

EID: 68049147000     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240802582125     Document Type: Article

References (40)

1. Jackson L, Jones DR, Scotting P, Sottile V. Adult mesenchymal stem cells: Differentiation potential and therapeutic applications. J Postgrad Med 2007;53:121-3.
2. Erices A, Conget P, Minguel JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000;109:235-42.
3. De Coppi P, Bartsch G, Atala A. Isolation of amniotic stem cell lines with potential for therapy. Nature Biotech 2006;25:100-6.
4. Katz AJ, Tholpady A, Tholpady SS et al. Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells 2005;23:412-23.
5. Prockop DJ. Marrow stromal cell as stem cells for nonhemopoietic tissues. Science 1997;276:71-4.
6. Caplan AL. Mesenchymal stem cells. J Orthop Res 1991;9:641-50.
7. Pittenger MF, Mackay AM, Beck SC et al. Multi-lineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7.
8. Friedestein AJ, Gorskaja JF, Kulagia NN. Fibroblast precursors in normal and irradiated mouse hemopoietic organs. Exp Hematol 1976;4:267-74.
9. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-9.
10. Villaron EM, Almeida J, Lopez-Holgado N et al. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation. Haematologica 2004;89:1421-7.
11. Poloni A, Leoni P, Buscemi L et al. Engraftment capacity of mesenchymal cells following hematopoietic stem cell transplantation in patients receiving reduced-intensity conditioning regimen. Leukemia 2006;20:329-35.
12. Krampera M, Cosmi L, Angeli R et al. Role of IFN-g in the immunomodulatory activity of human mesenchymal stem cell. Stem Cells 2005;24:386-98.
13. Le Blanc K, Tammik L, Sundberg B et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mytogenic responses independently of the MHC. Scand J Immunol 2003;57:11-20.
14. Krampera M, Glennie S, Dyson J et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific cells to their cognate peptide. Blood 2003;101:3722-9.
15. Glennie S, Soeiro I, Dyson PJ et al. Bone marrow mesenchymal stem cells induce division arrest anergy of activated Tcells. Blood 2005;105:2821-7.
16. Lazarus HM, Koc O, Devine SM et al. Cotransplantation of HLA-identical sibling culture expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005;11:389-98.
17. Le Blanc K, Rasmusson I, Sundberg B et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-41.
18. Horwitz EM, Prockop D, Fitzpatrick LA et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999;5:309-13.
19. Prockop DJ. Further proof of the plasticity of adult stem cells and their rule in tissue repair. J Cell Biol 2003;160:807-9.
20. Petite H, Viateau V, Bensaid W et al. Tissue-engineered bone regeneration. Nat Biotechnol 2000;18:959-63.
21. Barry FP, Boynton R, Liu B et al. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: Differentiationdependent gene expression of matrix components. Exp Cell Res 2001;268:189-200.
22. Quirici N, Soligo D, Bossolasco P et al. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 2002;30:783-91.
23. Colter DC, Class R, DiGirolamo CM et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. PNAS: Proc Natt Acad Sai, USA 2000;97:3213-8.
24. Deans RJ, Moseley A. Mesenchymal stem cells: Biology and potential clinical uses. Exp Hematol 2000;28:875-84.
25. Haynesworth SE, Baber M, Caplan AI. Cell surface antigens on human marrow-derived mesenchymal stem cells are detected by monoclonal antibodies. Bone 1992;13:69-80.
26. Roche S, Richard MJ, Favrot MC. Oct-4, Rex-1, and Gata-4 expression in human MSC increase the differentiation efficiency but not hTERT expression. J Cell Biochem 2006;515:1-10.
27. Sessarego N, Parodi A, Podestà A et al. Multipotent mesenchymal stem cells from amniotic fluid: Solid perspectives for clinical application. Haematologica 2008;93:339-46.
28. Castro-Malaspina H, Gay R, Resnick G et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980;56:289-301.
29. Kim J, Lee Y, Kim H et al. Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif 2007;40:75-90.
30. Sudres M, Norol F, Trenado A et al. Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. J Immunol 2006;176:7761-7.
31. Keyser KA, Beagles K, Kiem HP. Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation. Cell Transplant 2007;16:555-62.
32. Rasmusson I, Ringden O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003;76:1208-13.
33. Shahdadfar A, Fronsdal K, Haug T et al. In vitro expansion of human mesenchymal stem cells: Choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 2005;23:1357-66.
34. Le Blanc K, Samuelsson H, Lonnies L et al. Generation of immunosuppressive mesenchymal stem cells in allogeneic human serum. Transplantation 2007;84:1055-9.
35. Kocaoemer A, Kern S, Kluter H, Bieback K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for expansion of mesenchymal stem cells from adipose tissue. Stem Cells 2007;25:1270-8.
36. Bernardo ME, Avanzini M, Perotti C et al. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: Further insights in the search for a fetal calf serum substitute. J Cell Physiol 2006;211:121-30.
37. Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991;78:55-62.
38. Deschaseaux F, Gindraux F, Saadi R et al. Direct selection of human bone marrow mesenchymal stem cells using an anti- CD49a antibody reveals their CD45med,low phenotype. Br J Haematol 2003;122:506-17.
39. Gindraux F, Selmani Z, Obert L et al. Human and rodent bone marrow mesenchymal stem cells that express primitive stem cell markers can be directly enriched by using the CD49a molecule. Cell Tissue Res 2007;327:471-83.
40. Stewart K, Monk P, Walsh S et al. STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human stromal cells and their more differentiated progeny: A comparative investigation in vitro. Cell Tissue Res 2003;313:281-90.